Elias ElInati1,2, Camille Fossard3, Ozlem Okutman3,4, Houda Ghédir5, Samira Ibala-Romdhane5, Pierre F Ray6,7,8,9,10, Ali Saad5, Sylvianne Hennebicq6,7,8,9,10, Stéphane Viville3,4. 1. Département Génomique Fonctionnelle et Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 7104/Université de Strasbourg, 67404, Illkirch, France. elias.elinati@crick.ac.uk. 2. The Francis Crick Institute, Mill Hill Laboratory, The Ridgeway NW7 1AA, London, UK. elias.elinati@crick.ac.uk. 3. Département Génomique Fonctionnelle et Cancer, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de Santé et de Recherche Médicale (INSERM) U964/Centre National de Recherche Scientifique (CNRS) UMR 7104/Université de Strasbourg, 67404, Illkirch, France. 4. Centre Hospitalier Universitaire de Strasbourg, 67000, Strasbourg, France. 5. Laboratoire de Cytogénétique, Génétique Moléculaire et Biologie de la Reproduction Humaines. CHU Farhat Hached, 4000, Sousse, Tunisie. 6. Université Grenoble Alpes, Grenoble, F-38000, France. 7. Equipe "Génétique, Epigénétique et thérapies de l'Infertilité" Institut Albert Bonniot, INSERM U823, Grenoble, F-38000, France. 8. CHU de Grenoble, UF de Biochimie et Génétique Moléculaire, Grenoble, F-38000, France. 9. Fédération Française des CECOS, France, Paris. 10. Faculté de Médecine de Grenoble, Laboratoire d'Aide à la Procréation-CECOS, Laboratoire AGe, Imagerie, Modélisation, Équipe Génétique-Infertilité-Thérapeutique, Grenoble, France.
Abstract
PURPOSE: The aim of this study is to identify potential genes involved in human globozoopsermia. METHODS: Nineteen globozoospermic patients (previously screened for DPY19L2 mutations with no causative mutation) were recruited in this study and screened for mutations in genes implicated in human globozoospermia SPATA16 and PICK1. Using the candidate gene approach and the determination of Spata16 partners by Glutathione S-transferase (GST) pull-down four genes were also selected and screened for mutations. RESULTS: We identified a novel mutation of SPATA16: deletion of 22.6 Kb encompassing the first coding exon in two unrelated Tunisian patients who presented the same deletion breakpoints. The two patients shared the same haplotype, suggesting a possible ancestral founder effect for this new deletion. Four genes were selected using the candidate gene approach and the GST pull-down (GOPC, PICK1, AGFG1 and IRGC) and were screened for mutation, but no variation was identified. CONCLUSIONS: The present study confirms the pathogenicity of the SPATA16 mutations. The fact that no variation was detected in the coding sequence of AFGF1, GOPC, PICK1 and IRGC does not mean that they are not involved in human globozoospermia. A larger globozoospermic cohort must be studied in order to accelerate the process of identifying new genes involved in such phenotypes. Until sufficient numbers of patients have been screened, AFGF1, GOPC, PICK1 and IRGC should still be considered as candidate genes.
PURPOSE: The aim of this study is to identify potential genes involved in human globozoopsermia. METHODS: Nineteen globozoospermic patients (previously screened for DPY19L2 mutations with no causative mutation) were recruited in this study and screened for mutations in genes implicated in humanglobozoospermiaSPATA16 and PICK1. Using the candidate gene approach and the determination of Spata16 partners by Glutathione S-transferase (GST) pull-down four genes were also selected and screened for mutations. RESULTS: We identified a novel mutation of SPATA16: deletion of 22.6 Kb encompassing the first coding exon in two unrelated Tunisian patients who presented the same deletion breakpoints. The two patients shared the same haplotype, suggesting a possible ancestral founder effect for this new deletion. Four genes were selected using the candidate gene approach and the GST pull-down (GOPC, PICK1, AGFG1 and IRGC) and were screened for mutation, but no variation was identified. CONCLUSIONS: The present study confirms the pathogenicity of the SPATA16 mutations. The fact that no variation was detected in the coding sequence of AFGF1, GOPC, PICK1 and IRGC does not mean that they are not involved in humanglobozoospermia. A larger globozoospermic cohort must be studied in order to accelerate the process of identifying new genes involved in such phenotypes. Until sufficient numbers of patients have been screened, AFGF1, GOPC, PICK1 and IRGC should still be considered as candidate genes.
Entities:
Keywords:
GST pull-down; Globozoospermia; Linkage analysis; Male infertility; SPATA16
Authors: P Kuentz; F Vanden Meerschaut; E Elinati; M H Nasr-Esfahani; T Gurgan; N Iqbal; F Carré-Pigeon; F Brugnon; S A Gitlin; J Velez de la Calle; Z Kilani; P De Sutter; S Viville Journal: Hum Reprod Date: 2013-02-14 Impact factor: 6.918
Authors: Elias Elinati; Paul Kuentz; Claire Redin; Sara Jaber; Frauke Vanden Meerschaut; Joelle Makarian; Isabelle Koscinski; Mohammad H Nasr-Esfahani; Aygul Demirol; Timur Gurgan; Noureddine Louanjli; Naeem Iqbal; Mazen Bisharah; Frédérique Carré Pigeon; H Gourabi; Dominique De Briel; Florence Brugnon; Susan A Gitlin; Jean-Marc Grillo; Kamran Ghaedi; Mohammad R Deemeh; Somayeh Tanhaei; Parastoo Modarres; Björn Heindryckx; Moncef Benkhalifa; Dimitra Nikiforaki; Sergio C Oehninger; Petra De Sutter; Jean Muller; Stéphane Viville Journal: Hum Mol Genet Date: 2012-05-31 Impact factor: 6.150
Authors: Anika H D M Dam; Isabelle Koscinski; Jan A M Kremer; Celine Moutou; Anne-Sophie Jaeger; Astrid R Oudakker; Herman Tournaye; Nicolas Charlet; Clotilde Lagier-Tourenne; Hans van Bokhoven; Stephane Viville Journal: Am J Hum Genet Date: 2007-08-21 Impact factor: 11.025
Authors: J C Harper; K Aittomäki; P Borry; M C Cornel; G de Wert; W Dondorp; J Geraedts; L Gianaroli; K Ketterson; I Liebaers; K Lundin; H Mertes; M Morris; G Pennings; K Sermon; C Spits; S Soini; A P A van Montfoort; A Veiga; J R Vermeesch; S Viville; M Macek Journal: Hum Reprod Open Date: 2017-12-04
Authors: J C Harper; K Aittomäki; P Borry; M C Cornel; G de Wert; W Dondorp; J Geraedts; L Gianaroli; K Ketterson; I Liebaers; K Lundin; H Mertes; M Morris; G Pennings; K Sermon; C Spits; S Soini; A P A van Montfoort; A Veiga; J R Vermeesch; S Viville; M Macek Journal: Eur J Hum Genet Date: 2017-12-04 Impact factor: 4.246
Authors: Luiz G Guidi; Zoe G Holloway; Christophe Arnoult; Pierre F Ray; Anthony P Monaco; Zoltán Molnár; Antonio Velayos-Baeza Journal: Sci Rep Date: 2018-07-10 Impact factor: 4.379